0.00Open0.00Pre Close0 Volume0 Open Interest3.00Strike Price0.00Turnover266.87%IV-130.77%PremiumSep 20, 2024Expiry Date1.70Intrinsic Value100Multiplier26DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7888Delta0.3157Gamma0.73Leverage Ratio-0.0048Theta-0.0015Rho-0.58Eff Leverage0.0010Vega
Ocugen Stock Discussion
Ocugen, Inc. Announces FDA Approval of Expanded Access Program for Patients With Retinitis Pigmentosa
Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in Gardian Study for Stargardt Disease
No comment yet